Publication: Células Natural Killer y cáncer
Loading...
Official URL
Full text at PDC
Publication Date
2017-06
Authors
Advisors (or tutors)
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Citations
Exportar
Abstract
El cáncer es uno de los mayores problemas de salud pública global a día de hoy siendo, según datos del INE(Instituto Nacional de Estadística), la primera causa de muerte en los hospitales españoles. Múltiples frentes en investigación y tratamiento se encuentran abiertos actualmente y uno de ellos es la inmunoterapia con células natural killer (NK). En ella, mediante diferentes técnicas, se usan a las células NK para detectar y erradicar células tumorales. Pueden usarse bien como monoterapia o bien en combinación con otras células u otros fármacos, como los anticuerpos monoclonales.
Cancer is one of the major global public health issues nowadays. According to the Statistics National Institute’s data, cancer is the first cause of death in Spanish hospitals. Multiple research pathways and treatments are being looked into at the moment and one of them is immunotheraphy with Natural Killer(NK) cells. Its purpouse is to use NK cells to detect and erradicate malign cells. They can be used either as monotherapy or combined with other cells or drugs, as mAbs (monoclonal antibodies).
Cancer is one of the major global public health issues nowadays. According to the Statistics National Institute’s data, cancer is the first cause of death in Spanish hospitals. Multiple research pathways and treatments are being looked into at the moment and one of them is immunotheraphy with Natural Killer(NK) cells. Its purpouse is to use NK cells to detect and erradicate malign cells. They can be used either as monotherapy or combined with other cells or drugs, as mAbs (monoclonal antibodies).